BIBLIOGRAPHY

 

英文
1. Sawada T, Wu Y, Sachs DH, Iacomini J: CD4+ T cells are able to
reject class I disparate allografts. Transplantation 64: 335-340, 1997.
2. Sawada T, DellaPelle PA, Seebach JD, Sachs DH, Colvin RB, Iacomini J. Human
cell-mediated rejection of porcine xenogrfats in an immunodeficient mouse model.
3. Sawada T, Friedman T, Iacomini T: Conditions permitting short-term engraftment of
human T cells in RAG-1 mutant mice. Xenotransplant 4: 245-251, 1997.
4. Mayfield RS, Hayashi H, Sawada T, Bergen K, Guern CL, Sykes M, Sachs DH,
Iacomini J: The mechanism of specific prolongation of class I-mismatched skin
grafts induced by retrovirus gene therapy. Eur J Immunol 27: 1177-1181, 1997.
5. Hayashi H, Mayfield RS, Sawada T, Germana S, Sykes M, Iacomini J: Role of the
thymus in donor specific hypo- responsiveness induced by retroviral transduction of
bone marrow using an MHC class I gene David H Sachs, Christian L Guern.
Tranplant Proc 38: 1133, 1997.
6. Nakamura M, Fuchinoue S, Sato S, Hoshino T, Sawada T, Sageshima J, Kitajima K,
Tolinbara T, Fujita S, Nakajima T, Agishi T, Tanaka K: Clinical and radiological
features of two cases of tacrolimus-related posterior leukoencephalopathy in living
related liver transplantation. Transplant Proc 38: 1477-1478, 1988.
7. Tsuji K, Fuchinoue S, Kai K, Kawase T, Kitajima K, Sawada T, Nakajima I, Agishi
T: Culture of human parathyroid cells for transplantation . Transplant Proc 31: 2697,
1997.
8. Fuchimoto Y, Yamada K, Shimizu A, Yasumoto A, Sawada T, Huang C, Sachs DH:
Relationship between chimerism and tolerance in a kidney transplantation model. J
Immunol 162: 5704-5711, 1999.
9. Ishida H, Koyama I, Sawada T, Murakami T, Utsumi K, Sannomiya A, Tsuji K,
Tojimbara T, Nakajima I, Tanabe K, Fuchinoue S, Yamaguchi Y, Toma H, Agishi T:
Clinical utility of monitoring sialyl Lewis(X) (CD15S) antigen on peripheral
lymphocytes for the diagnosis and treatment of rejection after renal transplantation.
Transplantation 69: 59-63, 2000.
10. Ishida H, Koyama I, Sawada T, Murakami T, Tojimbara T, Nakajima I, Tanabe K,
Yamaguchi Y, Fuchinoue S, Toma H, Agishi T: Sialyl Lewis(x) (CD15s) monitoring
as a means to select antirejection therapy in patients with rejection after renal
transplantation: CD15s monitoring for treatment and diagnosis in patients with acute
rejection after renal transplantation. Transplantation 69: 2208-2211, 2000.
11. Ishida H, Koyama I, Sawada T, Utsumi K, Murakami T, Sannomiya A, Tsuji K,
Yoshimura N, Tojimbara T, Nakajima I, Tanabe K, Yamaguchi Y, Fuchinoue S,
Takahashi K, Teraoka S, Ito K, Toma H, Agishi T. Anti-AB titer changes inpatients
with ABO income- patibility after living related kidney transplantations: survey of
101 cases to determine whether splenectomies are necessary for successful
transplantation. Transplantation 70: 681-685, 2000.
12. Ishida H, Koyama I, Sawada T, Murakami T, Utsumi K, Sannomiya A, Tsuji K,
Tojimbara T, Nakajima I, Tanabe K, Fuchinoue S, Yamaguchi Y, Toma H, Agishi T:
Clinical utility of monitoring sialyl Lewis(x) (CD15s) antigen on peripheral
lymphocytes for the diagnosis and treatment of rejection after renal transplantation.
Transplant Proc 32: 265-268, 2000.
13. Sannomiya A, Tojimbara T, Fuchinoue F, Murakami T, Sawada T, Tsuji K, Kawase

T, Utsumi K, Koyama I, Ishida H, Nakajima I, Agishi T: Porcine liver
transplantation from non-heart-beating cadaver donor: effect of initial flushing with
cold versus warm UW solution. Transplant Proc 32: 1576-1577, 2000.
14. Tojimbara T, Fuchinoue S, Sannomiya A, Murakami T, Sawada T, Tsuji K, Kawase
T, Utsumi K, Koyama I, Ishida H, Nakajima I, Agishi T: Porcine liver
transplantation from non-heart-beating cadaver donors: effect of passive/active
venovenous bypass on graft function. Transplant Proc 32: 1626-1627, 2000.
15. Yashima J, Koyama I, Ishida H, Sawada T, Tojimbara T, Nakajima I, Fuchinoue S,
Agishi T: Successful conversion from tacrolimus to cyclosporine after kidney
transplantation. Transplant Proc 32: 11693, 2000.
16. Kawase T, Sawada T, Tojimbara T, Nakajima I, Fuchinoue S, Agishi T: TGF-β1 is
upregulated in chronically deteriorated renal allografts. Transplant Proc 32: 1781,
2000.
17. Utsumi K, Sawada T, Adachi E, Horita S, Tojimbara T, Nakajima I, Fuchinoue S,
Agishi T: Collagen type Ⅳ in acute rejection of kidney. Transplant Proc 32: 1785,
2000.
18. Kudoh S, Sawada T, Adachi E, Horita S, Tojimbara T, Nakajima I, Fuchinoue S,
Agishi T: Staining of collagen type Ⅳ in liver allografts. Transplant Proc 32: 2359,
2000.
19. Koyama I, Murakami T, Sawada T, Uruno K, Aoyagi Y, Nakajima I, Fuchinoue S,
Agishi T: Human cytokine production against cattle. Transplant Proc 32: 2500-2501,
2000.
20. Murakami T, Sawada T, Urakawa M, Uruno K, Aoyagi Y, Nakajima I, Fuchinoue S,
Agishi T: Characterization of bovine cells for xenotransplantation. Transplant Proc
32: 2502, 2000.
21. Bagley J, Sawada T, Wu Y, Iacomini J: A critical role for interleukin 4 in activating
alloreactive CD4 T cells. Nature Immunol 1: 257-261, 2000.
22. Murakami T, Sawada T, Yokoyama T, Uruno K, Aoyagi Y: Expression of alphaGal
epitope on COS-7 cells transfected with bovine alpha1-3 galactosyl- transferase. J
Tokyo Wom Med Univ 70: 23-29, 2000.
23. Yoshimura Y, Sawada T, Furusawa M, Fuchinoue S: Expression of xenoantigen
transformed human cancer cells to be susceptible to antibody- mediated cell killing.
Cancer Lett 164: 155- 160, 2001.
24. Koyama I, Sawada T, Urakawa M, Uruno K, Aoyagi Y: Human anti- bovine mixed
lymphocytes reaction is weaker than allogeneic reaction. J Tokyo Wom Med Univ
71: 173-178, 2001.
25. Ishii Y, Sawada T, Shimizu A, Tojimbara T, Nakajima I, Fuchinoue S, Teraoka S:
An
experimental sclerosing encapsulating peritonitis model in mice. Nephrol Dial
Transplant 16: 1262-1266, 2001.
26. Utsumi K, Shimizu A, Yamato M, Tojimbara T, Nakajima I, Adachi E, Fuchinoue S,
Sawada T: Alteration of collagen Ⅳ in acutely deteriorated renal allografts.
Transplantation 12: 1757-1765, 2001.
27. Tojimbara T, Sannomiya A, Murakami T, Sawada T, Kato Y, Tanoue M, Kai K,
Tsuji K, TKawase T, Ishida H, Nakajima I, Fuchinoue S: Effect of sodium
lactobionate sucrose solution on the function of liver grafts from non-heart-beating
pig donor. Transplant Proc 33: 889-890, 2001.

28. Ishii Y, Shimizu A, Sawada T, Tojimbara T, Nakajima I, Fuchinoue S, Teraoka S,
Yamaguchi Y, Yamanaka N: Injury of peritubular capillaries correlates with graft
function in chronic renal allograft nephropathy. Transplant Proc 33: 1213-1214,
2001.
29. Fuchinoue S, Sawada T, Tsuji K, Kai K, Tojimbara T, Nakajima I, Shiraga H, Ito K,
Teraoka S: Kidney transplantation after liver transplantation from the same donor:
four cases of successful steroid withdrawal. Transplantation 73: 948-952, 2002.
30. Sawada T, Yamada O, Yoshimura N, Hatori K, Fuchinoue S, Teraoka S:
Xenoantigen, an alpha Gal epitope-expression construct driven by the hTERT-
promoter, specifically kills human pancreatic cancer cell line. Canc Cell Int 2: 14,
2002.
31. Kawase T, Sawada T, Fuchinoue S, Teraoka S: Altered distribution of the α1 chain
of collagen Ⅳ in the chronic allograft nephropathy. J Tokyo Wom Med Univ 72:
419-427, 2002
32. Sawada T, Fuchinoue S, Teraoka S: Successful A1 to O, ABO-incompatible kidney
transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal
antibody infusions, splenectomy, and double filtration plasmapheresis.
Transplantation 74: 1207-1210, 2002.
33. Sawada T, Ishii Y, Tojimbara T, Nakajima I, Fuchinoue S, Teraoka S: The ACE
inhibitor, quinapril, ameriorates peritoneal fibrosis in an encapsulating peritoneal
sclerosis model in mice. Pharmacol Res 46: 505-510, 2002.
34. SendaiY, Sawada T, Urakawa M, Shinkai Y, Kubota K, Teraoka S, Hoshi H, Aoyagi .
Heterozygous disruption of the α1,3-galactosyltransferase gene in cattle.
Transplantation 6: 900-902, 2003.
35. Abe M, Sawada T, Horita S, Toma H, Yamaguchi Y, Teraoka S. C4d deposition in
peritubular capillary and alloantibody in the allografted kidney suffering severe
acute rejection. Clin Transplant 17(suppl: 10): 14-19, 2003.
36. Sawada T, Ando T, Sato S, Kubota K, Fuchinoue S, Teraoka S. Immunization by
blood-type antigen in human immunoglobulin products before ABO-incompatible
kidney transplantation. Clin Transplant, 18: 219-221, 2004.
37. Sawada T, Fuchinoue S, Kawase T, Kubota K, Teraoka S. Preconditioning Regimen
Consisting of Anti-CD20 Monoclonal Antibody Infusions, Splenectomy and DFPP
Enabled Non-Responders to Undergo ABO-Incompatible Kidney Transplantation.
Clin Transplant 18: 254-260, 2004.
38. Sawada T, Abe M, Kai K, Kubota K, Fuchinoue S, Teraoka S. β6 Integrin Is
Upregulated in Chronic Renal Allograft Dysfunction. Clin Transplant 18: 525-528,
2004.
39. Urakawa M, Ideta A, Sawada T, Aoyagi Y. Examination of a modified cell cycle
synchronization method and bovine nuclear transfer using synchronized early G1
phase fibroblast cells. Theriogenology 62: 714-728, 2004.
40. Sawada T, Shimizu A, Kubota K, Fuchinoue S, Teraoka S. Lobular damage caused
by cellular and humoral immunity in liver allograft rejection. Clin Transplant 19:
110-114, 2005.
41. Ishii Y, Sawada T, Kubota K, Fuchinoue S, Teraoka S, Shimizu A. Injury and
progressive loss of peritubular capillaries in the development of chronic allograft
nephropathy. Kidney Int 67: 321-332, 2005.
42. Sawada T, Kubota K. Courageous challenge: Clinical intestinal transplantation. J

Surg Oncol 92: 272-273, 2005.
43. Iso Y, Sawada T, Okada T, Kubota K. Loss of E-cadherin mRNA and gain of
osteopontin mRNA are useful markers for detecting early recurrence of HCV-related
hepatocellular carcinoma. J Surg Oncol 92: 304-311, 2005.
44. Ishii Y, Sawada T, Kubota K, Fuchinoue S, Teraoka S, Shimizu A. Loss of
peritubular capillaries in the development of chronic allograft nephropathy.
Transplant Proc 37: 981-983, 2005.
45. Iso Y, Sawada T, Shimoda M, Rokkaku K, Ohkura Y, Kubota K. Solitary AFP- and
PIVKA-II-producing hepatoid gastric cancer with giant lymph node metastasis.
Hepatogastroenterol 52: 1930-1932, 2005.
46. Iso Y, Sawada T, Kubota K.Hepatobiliary and Pancreatic: Massive splenomegaly. J
Gastroenterol Hepatol 20: 1942, 2005.
47. Kubota K, Kita J,Shimoda M,Rokkaku K,Kato M,Iso Y, Sawada T. Intraoperative
assessment of reconstructed vessels in living-donor liver transplantation, using a
novel fluorescence imaging technique. J Hepatobiliary Pancreat Surg 13: 100-104,
2006.
48. Sawada T, Kita J, Rokkaku K, Kato M, Shimoda M, Kubota K. Hepatectomy in
patients with nonuremic minimal renal failure. J Gastrointest Surg. 10: 740-745,
2006.
49. Furihata M, Sawada T, Okada T, Ishizuka M, Horie T, Takagi K, Nagata H, Kubota
K.Total colectomy improves altered distribution of regulatory T cells in patients
with ulcerative colitis. World J Surg 30: 590-597, 2006.
50. Sendai Y, Sawada T, Urakawa M, Shinkai Y, Kubota K, Hoshi H, Aoyagi Y.α1,3-
Galactosyltransferase-gene knockout in cattle using a single targeting vector with
loxP sequences and cre-expressing adenovirus. Transplantation 81: 760-766, 2006.
51. Iso Y, Sawada T, Rokkaku K, Furihata T, Shimoda M, Kita J, Kubota K. A case of
symptomatic Morgagni's hernia and a review of Morgagni's hernia in Japan (263
reported cases). Hernia 10: 521-524, 2006.
52. Shimoda M, kubota K, Sawada T, Katoh M, Furihata M, Iso Y, Ono Y, Fujimori T
Autoimmune pancreatitis diagnosed on the basis of immunohistology alone. A case
report. Pancreas 7: 478-481, 2006.
53. Sawada T, Sendai Y, Urakawa M, Shinkai Y, Hoshi H, Aoyagi Y, Kubota K
Cytological and histological study of pancreas from α1-3GT knock-out cattle.
Transplantation 82: Abstract 52, 2006.
54. Nakagawa A, Sawada T, Okada T, Ohsawa T, Adachi K, Kubota K. New
antineoplastic agent, MK615, from UME (a variety of) Japanese Apricot inhibits
growth of breast cancer cells in vitro. Breast J 13: 44-49, 2007.
55. Okada T, Sawada T, Kubota K. Deferoxamine enhances anti-proliferative effect of
interferon-gamma against hepatocellular carcinoma cells. Cancer Lett 248: 24-31,
2007.
56. Sawada T, Kubota K, Kita J, Furihata T, Iso Y, Kato M, Rokkaku K, Shimoda M.
Liver transplantation in diego blood disparity: a case report. Transplantation 83:
510-513, 2007.
57. Sawada T, Kubota K. Liver Transplantation for Hepatocellular Carcinoma. Dig Surg
24: 126-130, 2007.
58. Shimoda M, Iwasaki Y, Sawada T, Kubota K. Protective Effect of Ischemic
Preconditioning against Liver Injury after Major Hepatectomy Using the

Intermittent Pringle Maneuver in Swine. Pathobiology 74: 42-49, 2007.
59. Tagaya N, Tachibana M, Kijima H, Kakihara Y, Hamada K, Sawada T, Kubota K.
Laparoscopic treatment of paraesophageal hiatal hernia with incarceration of the
pancreas and jejunum. Surg Laparosc Endosc Percutan Tech 17: 313-316, 2007.
60. Okada T, Kubota K, Kita J, Kato M, Sawada T. Hepatocellular carcinoma with
chronic B-type hepatitis complicated by autoimmune hemolytic anemia: A case
report. World J Gastroenterol 13: 4401-4404, 2007.
61. Kubota K, Kita J, Rokkaku K, Iwasaki Y, Sawada T, Imura J, Fujimori T. Ectopic
hepatocellular carcinoma arising from pancreas: A case report and review of the
literature. World J Gastroenterol 13: 4270-4273, 2007.
62. Okada T; Sawada T, Kubota K. Asialoerythropoietin Has Strong Renoprotective
Effects Against Ischemia-Reperfusion Injury in a Murine Model. Transplantation
84: 504-510, 2007.
63. Mori S, Sawada T, Hamada K, Kita J, Shimoda M, Tagaya N, Kubota K.
Gastrectomy for patients with gastric cancer and non-uremic renal failure. World J
Gastroenterol 13: 4589-4592, 2007.
64. Okada T, Sawada T, Osawa T, Adachi M, Kubota K. A novel anti-cancer substance,
MK615, from Ume, a variety of Japanese Apricot, inhibits growth of hepatocellular
carcinoma cells by suppressing aurora A kinase activity. Hepato-Gastroenterol 78:
1770-1774, 2007.
65. Mori S, Sawada T, Okada T, Ohsawa T, Adachi M, Kubota K. New anti-
proliferative agent, MK615, from Japanese apricot "Prunus mume" induces striking
autophagy in colon cancer cells in vitro. World J Gastroenterol 13: 6512-6517,
2007.
66. Sawada T, Kita J, Nagata H, Shimoda M, Kubota K. Hepatectomy for metasta tic
liver tumor in patients with liver dysfunction. Hepato-Gastroenterol 54: 2306-2309,
2007.
67. Ishizuka M, Nagata H, Takagi K, Horie T, Sawada T, Kubota K. Usefulness of
Groshong Catheters for Central Venous Access via the External Jugular Vein. J
Invest Surg 21: 9-14, 2007.
68. Okada T, Sawada T, Kubota K. Rapamycin enhances the anti-tumor effect of
gemcitabine in pancreatic cancer cells. Hepato-Gastroenterol 54: 2129-2133, 2007.
69. Mori S, Sawada T, Kubota K Asialoerythropoietin is a strong modulator of
angiogenesis by bone-marrow cells. J Invest Surg 20: 357-362, 2007.
70. Okada T, Sawada T, Osawa T, Adachi M, Kubota K. MK615 inhibits pancreatic
cancer cell growth by dual inhibition of Aurora A and B kinases. World J
Gastroenterol 14: 1378-1382, 2008.
71. Kato M, Kubota K, Kita J, Shimoda M, Rokkaku K, Sawada T. Effect of Infra-
Hepatic Inferior Vena Cava Clamping on Bleeding During Hepatic Dissection: A
Prospective, Randomized, Controlled Study. World J Surg 32: 1082-1087, 2008.
72. Mori S, Sawada T, Okada T, Kubota K. Erythropoietin and its derivative protect the
intestine from severe ischemia/reperfusion injury in the rat. Surgery 143: 556-565,
2008.
73. Shimoda M, Iwasaki Y, Okada T, Sawada T, Kubota K. Protective effect of
Sivelestat in a porcine hepatectomy model prepared using an intermittent Pringle
method. Eur J Pharmacol 587: 248-252, 2008.
74. Shimoda M, Iso Y, Tomita S, Fujimori T, Murakami K, Sawada T, Kubota K.

Middle bile duct cancer with portal vein tumor thrombus. World J Surg Oncol 6: 48,
2008.
75. Ishizuka M, Sawada T, Kubota K. Influence of Preoperative Inflammation on
Outcomes of Colorectal Cancer Surgery. Ann Surg 247, 1085-1086, 2008.
76. Ishizuka M, Sawada T, Kubota K. A Critical Review of the Glasgow Prognostic
Score for Colorectal Cancer. Ann Surg 247, 1088, 2008.
77. Kijima H, Sawada T, Tomosugi N, Kubota K. Expression of hepcidin mRNA is
uniformly suppressed in hepatocellular carcinoma. BMC Cancer 8: 167, 2008.
78. Iso Y, Sawada T, Rokkaku K, Shimoda M, Kubota K. Ball-valve gastric tumor
associated with anomalous junction of the pancreatico-biliary ductal system and a
right-sided round ligament: Report of a case. Surg Today 38: 458-462, 2008.
79. Mori S, Tagaya N, Nakagawa A, Sawada T, Honma K, Kubota K. Undifferentiated
carcinoma of the esophagus with rapid growth of lymph node. A case report. Tumori
94: 411-415, 2008.
80. Mori S, Sawada T, Okada T, Kubota K. Anti-proliferative effect of interferon-
gamma is enhanced by iron chelation in colon cancer cell lines in vitro.
Hepatogastroenterology 55: 1274-1279, 2008.
81. Furihata T, Sawada T, Kita J, Iso Y, Kato M, Rokkaku K, Shimoda M, Kubota K.
Serum α-fetoporotein level per tumor volume reflects prognosis in patients with
hepatocellular carcinoma after curative hepatectomy. Hepatogastroenterology 55:
1705-1709, 2008.
82. Iso Y, Tagaya N, Kita J, Sawada T, Kubota K. Xanthogranulomatous lesion of the
pancreas mimicking pancreatic cancer. Med Sci Monit 14: CS130-133, 2008.
83. Perera MT, Shimoda M, Ane A, Yamazaki R, Sawada T, Kubota K. Life-threatening
bleeding from duodenal varices due to pancreatic arterio-venous malformation: role
of emergency pancreatodeuodenectomy. Hepatogastroenterology 55: 1553-1556,
2008.
84. Sawada T, Kita J, Rokkaku K, Kato M, Shimoda M, Kubota K. Outcome of urgical
resection for hilar cholangiocarcinoma in elderly patients. Hepatogastroenterology
55: 1971-1974, 2008.
85. Iso Y, Tagaya N, Nemoto T, Kita J, Sawada T, Kubota K. Incarceration of a large
cell neuroendocrine carcinoma arising from the proximal stomach with an
organoaxial gastric volvulus through an esophageal hiatal hernia: report of a case.
Surg Today 39: 148-152, 2009.
86. Ishizuka M, Kita J, Shimoda M, Rokkaku K, Kato M, Sawada T, Kubota K.
Systemic inflammatory response predicts postoperative outcome in patients with
liver metastases from colorectal cancer. J Surg Oncol 100: 38-42, 2009.
87. Shimoda M, Sawada T, Kubota K. Thymidylate synthetase and dihydropyrimidine
dehydrogenase are upregulated in pancreatic and biliary tract cancers. Pathobiology
76: 193-198, 2009.
88. Iso Y, Sawada T, Tagaya N, Kato M, Rokkaku K, Shimoda M, Kita J, Kubota K.
Pancreatic juice leakage is a risk factor for deep mycosis after pancreatic surgery.
Surg Today 39: 326-331, 2009.
89. Ishizuka M, Sawada T, Okada T, Nagata H, Takagi K, Horie T, Kubota K. Influence
of tumor peroxisome proliferator-activated receptor gamma and delta expression on
postoperative mortality of patients undergoing colorectal cancer surgery. J Invest
Surg 22: 105-111, 2009.

90. Iwasaki Y, Sawada T, Mori S, Iso Y, Katoh M, Rokkaku K, Kita J, Shimoda M,
Kubota K. Estimating glomerular filtration rate preoperatively for patients
undergoing hepatectomy. World J Gastroenterol 15: 2252-2257, 2009.
91. Sawada T, Ishii Y, Nakajima I, Fuchinoue S, Kubota K, Teraoka S. An experimental
model of encapsulating peritoneal sclerosis. Perit Dial Int 29 (suppl 2): S49-50,
2009.
92. Okada T, Sawada T, Kubota K. Rapamycin inhibits growth of cholangiocarcinoma
cells. Hepatogastroenterology 56: 6-10, 2009.
93. Shimoda M, Sawada T, Kubota K. Thymidylate synthase and dihydropyrimidine
dehydrogenase are upregulated in pancreatic and biliary tract cancers. Pathobiology
76: 193-198, 2009.
94. Shimoda M, Sawada T, Iwasaki Y, Mori S, Kijima H, Okada T, Kubota K.
Erythropoietin strongly protects the liver from ischemia-reperfusion injury in a pig
model. Hepatogastroenterology 56: 470-475, 2009.
95. Ishizuka M, Nagata H, Takagi T, Sawada T, Kubota K. Valve system does not
reduce the catheter-related bloodstream infection. J Invest Surg 22: 430-434, 2009.
96. Iwasaki Y, Sawada T, Hiroaki Kijima, Takayuki Kosuge, Masato Katoh, Rokkaku
K, Kita J, Shimoda M, Kubota K. Estimated glomerular filtration rate is superior to
measured creatinine clearance for predicting postoperative renal dysfuntion in
patients undergoing pancreatoduodenectomy. Pancreas 39: 20-25, 2010.
97. Sawada T, Solly M, Kita J, Shimoda M, Kubota K. An alternative tool for
intraoperative assessment of renal vasculature after revascularization of a
transplanted kidney. Am J Surg 199: e69-71, 2010.
98. Kosuge T, Sawada T, Iwasaki Y, Kita J, Shimoda M, Tagaya N, Kubota K. eGFR is
a reliable preoperative renal function parameter in patients with gastric cancer.
World J Gastroenterol 16: 2417-2420, 2010.
99. Kosuge T, Sawada T, Shimoda M, Kita J, Tomosugi N, Kubota K. Increased
hepcidin production impairs iron metabolism after pancreatoduodenectomy. World J
Surg 34: 2452-2456, 2010.
100. Kato M, Sawada T, Kita J, Shimoda M, Kubota K. Erythropoietin ameliorates
early ischemia-reperfusion injury following Pringle maneuver. World J
Gastroenterol 16: 4838-4845, 2010.
101. Sakuraoka Y, Sawada T, Okada T, Shiraki T, Miura Y, Hiraishi K, Ohsawa T,
Adachi M, Takino J, Takeuchi M, Kubota K. MK615 decreases RAGE expression
and inhibits TAGE-induced proliferation in hepatocellular carcinoma cells. World J
Gastroenterol 16: 5334-5441, 2010.
102. Shimoda M, Kato M, Kita J, Sawada T, Kubota K. The glasgow prognostic score is
a good predictor of treatment outcome in patients with unresectable pancreatic
cancer. Chemotherapy 56: 501-506, 2010.
103. Fuchinoue S, Ishii Y, Sawada T, Murakami T, Iwadoh K, Sannomiya A, Koyama I,
Kubota K, Tojimbara T, Nakajima I, Teraoka S. The 5-year outcome of ABO-
incompatible kidney transplantation with rituximab induction. Transplantation, 91:
863-857, 2011.
104. Ishii Y, Sawada T, Murakami T, Sakuraoka Y, Shiraki T, Shimizu A, Kubota K,
Fuchinoue S, Teraoka S. Renoprotective effect of erythropoietin against ischemia-
reperfusion injury in a non-human primate model. Nephrol Dial Transplant 26:
1157-1162, 2011.

105. Sawada T, Kubota K, Kita J, Kato M, Shiraki T, Park K, Shimoda M. Clinical
outcome of hepatectomy for hepatocellular carcinoma ≤ 2cm. World J Surg 35, 377-
385, 2011.
106. Ishizuka M, Kubota K, Kita J, Shimoda M, Kato M, Sawada T. Usefulness of a
modified inflammation-based prognostic system for predicting postoperative
mortality of patients undergoing surgery for primary hepatocellular carcinoma. J
Surg Oncol 103: 801-806, 2011.
107. Ishizuka M, Kubota K, Kita J, Shimoda M, Kato M, Sawada T. Impact of an
inflammation-based prognostic system on patients undergoing surgery for
hepatocellular carcinoma: a retrospective study of 398 Japanese patients. Am J Surg
203: 101-106, 2011.
108. Shiraki T, Miura Y, Sawada T, Okada T, Sakuraoka Y, Muto T, Kubota K.
Glycated albumin suppresses glucose-induced insulin secretion by impairing
glucose metabolism in rat pancreatic β-cells. Nutr Metab 8: 20, 2011.
109. Ishizuka M, Kubota K, Kita J, Shimoda M, Kato M, Sawada T. Duration of hepatic
vascular inflow clamping and survival after liver resection for hepatocellular
carcinoma. Br J Surg 98: 1284-1290, 2011.
110. Ishizuka M, Kubota K, Kita J, Shimoda M, Kato M, Sawada T. Underweight
patients show an increased rate of postoperative death after surgery for
hepatocellular carcinoma. J Surg Oncol 104: 809-813, 2011.
111. Sakuraoka Y, Sawada T, Shiraki T, Park K, Sakurai Y, Tomosugi N, Kubota K.
Analysis of hepcidin expression: In situ hybridization and quantitative polymerase
chain reaction from paraffin sections. World J Gastroenterol, 18: 3727-3731, 2012.
112. Ishizuka M, Kubota K, Kita J, Shimoda M, Kato M, Sawada T. Impact of grading
of liver metastasis on postoperative outcome in patients with liver metastases from
colorectal cancer. Hepatogastroenterology 59: 54-58, 2012.
113. Ishizuka M, Kubota K, Kita J, Shimoda M, Kato M, Sawada T. Intraoperative
observation using a fluorescence imaging instrument during hepatic resection for
liver metastasis from colorectal cancer. Hepatogastroenterology 59: 90-92, 2012.
114. Park KH, Sawada T, Kosuge T, Kita J, Shimoda M, Tomosugi N, Kubota K.
Surgical inflammation induces hepcidin production after abdominal surgery. World J
Surg 36: 800-806, 2012.
115. Shimoda M, Katoh M, Yukihiro I, Kita J, Sawada T, Kubota K. Body mass index is
a risk factor of pancreatic fistula after pancreaticoduodenectomy. Am Surg 78: 190-
194, 2012.
116. Park KH, Sawada T, Murakami T, Ishii Y, Yasuo M, Urakawa M, Aoyagi Y,
Fuchinoue S, Kubota K. Anti-human leukocyte antigen-DR (MHC class II)
humanized monoclonal antibody, IMMU-114, suppresses human to bovine cellular
responses. J Surg Res178: 472-477, 2012.
117. Park KH, Sawada T, Murakami T, Ishii Y, Yasuo M, Fuchinoue S, Goldenberg
DM, Kubota K. Anti-class II -DR humanized monoclonal antibody, IMMU-114,
blocks allogeneic immune response. Am J Surg 204: 527-534, 2012.
118. Miura Y, Hori Y, Kimura S, Hachiya H, Sakurai Y, Inoue K, Sawada T, Kubota K.
Triphenyltin impairs insulin secretion by decreasing glucose-induced NADP(H) and
ATP production in hamster pancreatic β-cells. Toxicology 299: 165-171, 2012.
119. Iwasaki Y, Kubota K, Kita J, Katoh M, Shimoda M, Sawada T, Iso Y. Single-stage
intraoperative transhepatic biliary stenting in patients with unresectable

hepatobiliary pancreatic tumors. Surg Endosc 27: 505-513, 2013.
120. Sakuraoka Y, Sawada T, Shiraki T, Park K, Sakurai Y, Tomosugi N, Kubota K.
Analysis of hepcidin expression: in situ hybridization and quantitative polymerase
chain reaction from paraffin sections. World J Gastroenterol 18: 3727-3721, 2012.
121. Ishizuka M, Kubota K, Kita J, Shimoda M, Kato M, Sawada T. Survival after
surgery for hepatocellular carcinoma in relation to presence or absence of viral
infection. Am J Surg 206: 187-193, 2013.
122. Sawada T, Kawahara H. Cost of hemodialysis after coverage by national health
insurance in Japan: a sharing experience with Indonesian health reform system.
Med J Indones 23: 122-124, 2014.
123. Sawada T, Kawahara H. Strategy for reduction of medical costs and growth of the
healthcare industry after establishment of the National Health Insurance system in
Japan:Lessons for the Indonesian health care reform system -Ⅱ-. Med J Indones
23: 182-184, 2014.

 

和文
1. ベンチサージェリーで腎動脈瘤を切除し移植した1例. 腎と透析, 1992, 32, 479-481, 河野
登起彦、大場忍、石川暢夫、八木沢隆、中沢速和、高橋公太、寺岡慧、東間紘、阿岸鉄
三、太田和夫.
2. 経皮的恒久型ペースメーカー植え込みと高カロリー輸液用カテーテル挿入により両側鎖
骨下静脈血栓症をきたした１例. 透析会誌, 1993, 26, 207－212, 澤田登起彦、中川芳彦、
吉岡隆、米倉増男、深沢達也、太田和夫.
3. 内シャント静脈高血圧症23例の検討. 透析会誌, 1993, 1777-1782, 中川芳彦、太田和夫
、佐藤雄一、村上徹、提嶋淳一郎、澤田登起彦、河合達郎、渕之上昌平、寺岡慧、阿岸
鉄三.
4. 拒絶反応機序‐特にCD4陽性T細胞の役割. 今日の移植, 1999, 12, 5-9, 澤田登起彦.
5. ヒト副甲状腺細胞の培養. Organ　Biology, 1999, 6, 73-80, 辻和彦、澤田登起彦、増田昭
博、甲斐耕太郎、北島久視子、春口洋昭、林哲郎、唐仁原全、中島一朗、笠島武、渕之
上昌平、阿岸鉄三.
6. ウシ胎児線維芽細胞におけるαGal抗原に関する検討. 移植会誌, 1999, 34, 367-371, 村
上徹、澤田登起彦、中島一朗、渕之上昌平、阿岸鉄三.
7. 腎移植における経口タクロリムス導入療法. 移植会誌, 1999, 6, 135-140, 唐仁原全、君川
正昭、小山一郎、石田英樹、内海謙、三宮彰仁、川瀬友則、辻和彦、甲斐耕太郎、澤田
登起彦、村上徹、中島一朗、渕之上昌平、寺岡慧、東間紘、阿岸鉄三.
8. 二次性上皮小体機能亢進症患者より得られた上皮小体細胞の同種免疫原性に関する
検討. 東女医大雑誌, 2000, 70, 67-71, 辻和彦, 澤田登起彦, 渕之上昌平, 阿岸鉄三.
9. ヒト副甲状腺細胞の簡便な回収、培養法についての基礎研究. 腎と透析, 2000, 48（別冊
）, 94-95, 辻和彦、澤田登起彦、中島一朗、渕之上昌平、阿岸鉄三.
10. ミコフェノール酸モフェチル. 新しい治療薬, 2000, 前期, 162-175, 渕之上昌平、澤田登起
彦、太田和夫.
11. 創傷治癒の機序と腎不全の影響. 腎不全の外科－病態とマネージメント（太田和夫監修
、阿岸鉄三、東間紘、寺岡慧編）, 2000, pp344①17－21, 春口洋昭、中村道郎、澤田登起
彦.

12. 心停止ドナーからの肝移植における各種灌流・保存液の検討. 肝臓, 2000, 41, 300-30１,
唐仁原全、三宮彰仁、村上徹、澤田登起彦、甲斐耕太郎、辻和彦、小山一郎、内海謙、
石田英樹、中島一郎、渕之上昌平、阿岸鉄三.
13. 心停止ドナーを用いたブタ肝移植の研究－灌流保存液の影響. 東女医大総研紀要,
2000, 20, 88－89, 唐仁原全、三宮彰仁、、澤田登起彦、村上徹、中島一朗、渕之上昌平.
14. ウシ胎児線維芽細胞を核体とした除核成熟卵子との電気融合率に関する検討. 東女医
大雑誌, 2001, 71, 823-827, 浦川真実、宇留野勝好、青柳敬人、澤田登起彦.
15. クローン技術の医療応用. 東女医大雑誌, 2002, 72, 103-107, 澤田登起彦.
16. シトルリン血症に対する生体肝移植の経験ー小児発症型（ＣＴＬＮ１）と成人発症型
（ＣＴＬＮ２）－. 日本移植学会誌, 2003, 38, 143-147, 安藤哲郎、唐仁原全、甲斐耕太郎、
川瀬友則、中村道郎、君川正昭、澤田登起彦、中島一朗、渕之上昌平、寺岡慧、白髪宏
司、伊藤克巳、下江俊成、和田尚弘、小林圭子、佐伯武頼.
17. 抗CD20モノクローナル抗体を用いたABO血液型不適合腎臓移植. 今日の移
植, 2003, 16, 45-49, 澤田登起彦、渕之上昌平、寺岡慧.
18. クローン技術の臓器移植への応用. Annual Review 腎臓. 169-172. 2004, 澤田
登起彦、窪田敬一.
19. ラ氏島移植の臨床. Annual Review 消化器, 2004, 55-59, 澤田登起彦、窪田敬一.
20. ABO血液型不適合腎移植と抗CD２０モノクローナル抗体. 腎と透析, 2005, 59腎
不全外科2005, 55－57, 澤田登起彦、渕之上昌平、寺岡慧、窪田敬一.
21. HCCと播種病変を伴ったCCCによる同時性重複癌の１例. Liver Cancer,
205－212, 礒幸博、下田貢、六角丘、阿部暁人、澤田登起彦、窪田敬一.
22. 異種移植とクローン技術. 栃木臓器移植推進協会だより, 2006, 16, 7, 澤田登起彦.
23. 肝原発を示唆するカルチノイドの１例. Liver Cancer, 2006, 12, 18－23, 加藤正
人、北順二、下田貢、六角丘、礒幸博、澤田登起彦、窪田敬一、市川一仁、藤盛孝博.
24. 下部胆管癌の診断と治療. 外科治療, 2006, 94, 795－800, 澤田登起彦、下田貢、窪
田敬一.
25. 保存期腎不全患者における肝切除術の安全性に関する検討. 腎と透析, 2006,
60腎不全外科2006, 96－97, 澤田登起彦、北順二、加藤正人、六角丘、下田貢、窪田敬
一.
26. 膵頭十二指腸切除後の深在性真菌症に対してミカファンギンが奏効した１例. Progress in
Medicine, 2006, 26, 259-262, 礒幸博、下田貢、降旗正、澤田登起彦、窪田敬一.
27. PET scanにより発見された膵鈎部浸潤性膵管癌の１例. 胆と膵, 2006, 27, ６８５－６８８,
大谷太郎、礒幸博、降旗正、下田貢、澤田登起彦、窪田敬一.
28. TAEおよびCDDP動注療法後にicteric type hepatomaに進展した胆管腫瘍栓
に対し外科治療を必要とした肝細胞癌症例. Liver Cancer, 2006, 12, １８２－
１８９, 北順二、窪田敬一、加藤正人、礒幸博、六角丘、下田貢、澤田登起彦.
29. 転移性肝癌の治療戦略. Annual Review消化器2007, 2007, 247-254, 澤田登起彦、窪
田敬一.
30. ヒト主要組織適合抗原. 栃木臓器移植推進協会だより, 2007, 17, 7, 澤田登起彦.
31. 臨床画像的に限局性結節性過形成との鑑別に苦慮した中分化型肝細胞癌の
１例. Liver Cancer, 2007, 13, 68-75, 礒幸博、北順二、喜嶋博章、根本猛彦、澤田登起
彦、窪田敬一、村上康二、富田茂樹、藤盛孝博.
32. A case of gastric endocrine carcinoma in a patient with end-stage
renal disease. 腎と透析, 2007, 62腎不全外科, ６９－７３, Sawada T, Rokkaku K,
Shimoda M, Kubota K.
33. 膵癌診断におけるPET-CTの有用性. 医学のあゆみ, 2007, 222, 42-44, 礒幸博、澤
田登起彦、窪田敬一、村上康二.
34. ラジオ波焼灼療法後の再発肝細胞癌に対して外科治療を施行した１例. Liver
Cancer, 2007, 13, 152-159, 加藤正人、北順二、下田貢、六角丘、礒幸博、澤田登起彦、
窪田敬一、富田茂樹、藤盛孝博.
35. 先天性胆管拡張症・膵胆道合流異常症. 外科, 2007, 69, 1537-1543, 澤田登起彦、
窪田敬一.
36. 移植と癌. 栃木臓器移植推進協会だより, 2008, 18,7, 澤田登起彦.
37. 吻合にアナストクリップを用いた人工血管移植の経験. 腎と透析, 2008, 63腎
不全外科2006, 85-87, 加藤正人、澤田登起、小菅崇之、窪田敬一.

38. 間歇的肝門部遮断を用いたブタ肝切除モデルにおけるエダラボンの保護効
果. Medical Postgraduates, 2008, 46, 52-58, 岩崎喜実、下田貢、岡田としえ、澤田登起
彦、窪田敬一.
39. 術後胆道合併症防止とその対策　Ⅱ.良性疾患　3.胆道拡張症. 外科, 2008,
70, 955-958, 澤田登起彦、窪田敬一.
40. 混合型肝癌の５切除例. Liver Cancer, 2008, 14, １８１－１８９, 小菅崇之、北順二、加
藤正人、六角丘、下田貢、澤田登起彦、窪田敬一.
41. 実験動物センター利用雑感. 獨協医科大学実験動物センター紀要2007, 2008, 8,
１４－１５, 澤田登起彦.
42. 虚血再灌流傷害に対するEPOの腎保護効果について. 腎と透析, 2009, 66腎不全
外科2009, 69-70, 澤田登起彦、岡田としえ、窪田敬一.
43. 人工血管穿刺時にクランプキャス先端が残存、抜去し得た１例. 腎と透析,
2009, 66腎不全外科2009, １０５－１０６, 加藤正人、、澤田登起彦、小菅崇之、窪田敬一

.